Wyniki leczenia ostrej białaczki limfoblastycznej u dzieci za pomocą protokołu ALL IC BFM 2002. Badania jednoośrodkowe.
Derwich K, zając-Spychała O, Januszkiewicz-Lewandowska D, Dawidowska M, Wachowiak J;
Acta Haematol Polon, 2011, 42 (3): 567-572.
Publikacje
Publikacje pracowników w ePub
The importance of the genetic methods for the early diagnostics and the prognosis of the course of large bowel adenomatous polyposis.
Lozynska M, Pławski A, Lozynsky Y;
Onkologija, 2011, 14 (4): 282-287.
The genetics of keratoconus.
Nowak DM, Gajęcka M;
Middle East Afr J Ophthalmol, 2011, 18 (1): 2–6.
Tiopurine S-methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction Or cessation of 6-mercaptopurine doses during maintenance therapy: the Polish multicenter analysis.
Peregud-Pogorzelski J, Tetera-Rudnicka E, Kurzawski M, Brodkiewicz A, Adrianowska N, Mlynarski W, Januszkiewicz D, Drozdzik M;
Pediatr Blood Cancer, 2011, 57 (4): 578-582.
Prolonged exposure to growth hormone impairs insulin signaling in the heart.
Miguet JG, Giani JF, Martinez CS, Munoz MC, Gonzalez L, Sotelo AI, Boparai RK, Masternak MM, Bartke A, Dominici FP, Turyn D;
J Mol Endocrinol, 2011, 47 (2): 167–177.
Post-transcriptional regulation of IGF1R by key microRNAs in long-lived mutant mice.
Liang R, Khanna A, Senthilkumar M, Li N, Sarojini H, Kopchick JJ, Masternak MM, Bartke A, Wang E;
Aging Cell, 2011, 10: 1080-1088.
Reduced number of VSEls in the bone marrow of growth hormone transgenic mice indicates that chronically elevated Igf1 level accelerates age-dependent exhaustion of pluripotent stem cell pool: a novel view on aging.
Kucia M, Shin DM, Liu R, Ratajczak J, Bryndza E, Masternak MM, Bartke A, Ratajczak MZ;
Leukemia, 2011, 25: 1370-1374.
T-cell acute lymphoblastic leukemia: recent molecular biology findings.
Kraszewska MD, Dawidowska M, Szczepański T, Witt M;
Brit J Haematol, 2011, 156: 303-315.
Recurrent amplification of 22q11 band region in laryngeal squamous cell carcinoma results in overexpression of the CRKL but not the MAPK1 oncogene.
Kostrzewska-Poczekaj M, Giefing M, Jarmuż M, Brauze D, Pelińska K, Grenman R, Bartochowska A, Szyfter W, Szyfter K;
Cancer Biomark, 2010/11, 8 (1): 11-19.
Renal pro-apoptotic proteins are reduced by growth hormone resistance but not by visceral fat removal.
Gesing A, Bartke A, Wang F, Karbownik-Lewińska M, Masternak MM;
Biology Chemistry, 2011, 392: 475-481.